Latest Breaking News On - Washington university siteman cancer center - Page 1 : comparemela.com

Greenwich LifeSciences, Inc : Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

Greenwich LifeSciences, Inc : Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

University of nebraska medical centerUnited statesBaylor universityUniversity of miamiSan franciscoSalt lake cityFeinberg schoolNew yorkSan antonioClifton parkRocky mountainNorthwestern universityPalo altoNordrhein westfalenStony brookBaylor college of medicine

Johns named to the SWIC Foundation Board

Johns named to the SWIC Foundation Board
thetelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thetelegraph.com Daily Mail and Mail on Sunday newspapers.

United statesElizabeth johnsProfessor of nursing at maryville universityDeaconess college of nursingMaryville universityLouis universityFoundation boardSouthwestern illinois college foundation boardNurse practitionerAssistant professorSouthwestern illinois college foundationHematology nurse practitionerWashington university siteman cancer centerDeaconess collegeGeriatric acute care nurse practitioner

No improvement in freedom from progression rates for patients: Study

Results from the NRG Oncology NRG-RTOG 0232 clinical trial adding external beam radiotherapy (EBRT) to brachytherapy (BT) in men with intermediate-risk prostate cancer indicate that there was no improvement in freedom from progression (FFP) rates for patients.

United statesJeff michalskiDanielle ellisWashington university siteman cancer centerNational cancer instituteClinical oncologyStudy lead authorWashington university siteman cancerProstate cancerClinical trialXternal beam radiotherapyRadiation therapy

EBRT Does Not Improve Outcomes for Intermediate-Risk Prostate Cancer

EBRT Does Not Improve Outcomes for Intermediate-Risk Prostate Cancer
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesJeff michalskiRadiation therapy oncology groupWashington university siteman cancer centerNational clinical trials networkNational cancer instituteNational surgical adjuvant breastGynecologic oncology groupClinical oncologyIntermediate risk prostate cancerBowel project

Clinical trial: Adding EBRT to brachytherapy does not improve outcomes for men with intermediate-risk prostate cancer

Clinical trial: Adding EBRT to brachytherapy does not improve outcomes for men with intermediate-risk prostate cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesJeffm michalskiJeff michalskiWashington university siteman cancer centerClinical oncologyIntermediate risk prostate cancerClinical trial